Despite warnings, drug giant took long path to Vioxx recall.
作者信息
Berenson Alex, Harris Gardiner, Meier Barry, Pollack Andrew
出版信息
N Y Times Web. 2004 Nov 14:A1, A32.
PMID:15599982
Abstract
摘要
相似文献
1
Despite warnings, drug giant took long path to Vioxx recall.
N Y Times Web. 2004 Nov 14:A1, A32.
2
The vexations of Vioxx.
CMAJ. 2006 Feb 14;174(4):444-5. doi: 10.1503/cmaj.060041.
3
NEJM editor gives pretrial evidence in Vioxx case.
BMJ. 2006 Feb 4;332(7536):255. doi: 10.1136/bmj.332.7536.255-a.
4
The sad story of Vioxx, and what we should learn from it.
Cleve Clin J Med. 2004 Dec;71(12):933-4, 936, 938-9. doi: 10.3949/ccjm.71.12.933.
5
Failing the public health--rofecoxib, Merck, and the FDA.
N Engl J Med. 2004 Oct 21;351(17):1707-9. doi: 10.1056/NEJMp048286. Epub 2004 Oct 6.
6
Vioxx doctors wooed by Merck are now its foes.
Wall St J (East Ed). 2006 Mar 10:B1, B3.
7
Merck cleared in personal injury case against Vioxx.
BMJ. 2005 Nov 12;331(7525):1101. doi: 10.1136/bmj.331.7525.1101-a.
8
Evaluating drug effects in the post-Vioxx world: there must be a better way.
Circulation. 2006 May 9;113(18):2173-6. doi: 10.1161/CIRCULATIONAHA.106.625749.
9
Painful withdrawal for makers of Vioxx: pulling of arthritis drug raises questions on marketing, safety risks.
Washington Post. 2004 Oct 18:A1, A8.
10
The Vioxx debacle.
IEEE Eng Med Biol Mag. 2005 Mar-Apr;24(2):106-9. doi: 10.1109/memb.2005.1411356.
引用本文的文献
1
Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.
BMC Womens Health. 2017 Oct 2;17(1):97. doi: 10.1186/s12905-017-0449-0.
2
Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment.
J Gen Intern Med. 2008 Jan;23 Suppl 1(Suppl 1):57-63. doi: 10.1007/s11606-007-0275-4.
3
What have we learnt from Vioxx?
BMJ. 2007 Jan 20;334(7585):120-3. doi: 10.1136/bmj.39024.487720.68.
Zotero 插件